What Did Lawmakers Discuss at the House Hearing on Health AI?

Lawmakers and health experts convened on Capitol Hill this week to discuss the use of AI in healthcare. They highlighted the technology’s potential to reduce administrative burdens and boost care access in rural areas — while also warning about oversight gaps and the risks of AI-driven prior authorization. The post What Did Lawmakers Discuss at…

Read More

Embracing Transparency, FDA Will Make All Future Drug Rejection Letters Public

FDA Commissioner Marty Makary said publishing complete response letters recognizes public interest in the transparency and credibility of agency decision-making about drugs. He also said the move complies with an executive order that covers the communication of scientific data. The post Embracing Transparency, FDA Will Make All Future Drug Rejection Letters Public appeared first on…

Read More

What’s Missing from Your Tool Chest? How Health Plans Can Improve Star Ratings in Medicare Advantage

The pathway for health plans to achieve better Star ratings performance in their MA business depends on creating an ecosystem where providers are supported with the right tools and resources, incentives are properly aligned, and the member experience remains central to all initiatives. The post What’s Missing from Your Tool Chest? How Health Plans Can…

Read More

Startup Treeline Bio Emerges From the Shadows With $1B+ Raised and 3 Cancer Drugs in the Clinic

Eschewing the traditional model of financing biotech startups milestone to milestone to support a lead asset, Treeline Biosciences’ well-funded pipeline is comprised of multiple complementary programs. Select investors have supported the approach of Treeline, which said it has raised more than $1.1 billion to date. The post Startup Treeline Bio Emerges From the Shadows With…

Read More